Liquid chromatographic analysis method for detecting plasma concentrations of oxcarbazepine and oxcarbazepine metabolite in blood

A technology for liquid chromatography analysis and metabolites, which is applied in the field of detecting the content of the antiepileptic drug oxcarbazepine and its metabolites in blood, and can solve complex pretreatment operations, unsuitable for large-throughput sample detection, and inaccurate results, etc. problems, achieve the effect of simple and fast detection process, shorten sample analysis time, and reduce toxic and side effects

Inactive Publication Date: 2018-06-22
BEIJING HARMONY HEALTH MEDICAL DIAGNOSTICS CO LTD
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, high-performance liquid chromatography-mass spectrometry has high analysis costs, high requirements on the site, and requires professionals to operate, so it is not suitable for widespread use in small and medium-sized hospitals.
High-performance liquid chromatography has the advantages of accurate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Liquid chromatographic analysis method for detecting plasma concentrations of oxcarbazepine and oxcarbazepine metabolite in blood
  • Liquid chromatographic analysis method for detecting plasma concentrations of oxcarbazepine and oxcarbazepine metabolite in blood
  • Liquid chromatographic analysis method for detecting plasma concentrations of oxcarbazepine and oxcarbazepine metabolite in blood

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0038] (1) Calibration of standard solution

[0039] First, pipette 10 μL of standard working solution, 10 μL of internal standard working solution and 90 μL of blank serum or plasma into centrifuge tubes to prepare at least three standard solutions with different concentrations. After vortex mixing at 1500rpm for 1min, add extractant 1000μL methyl tert-butyl ether, and after vortex mixing at 2000rpm for 5min, centrifuge at 12000rpm for 10min at a high speed to obtain the supernatant. Pipette 800 μL of the supernatant of the standard solution and put it in another centrifuge tube, at room temperature with N 2 Dry slowly; add 100 μL of complex solution composed of 45:32:23 water, acetonitrile and methanol to the above-mentioned blow-dried centrifuge tube to dissolve, then vortex and mix at 2000rpm for 1min, and then in 12000rpm Centrifuge at high speed for 5 minutes at a rotating speed to obtain the supernatant, pipette the above-mentioned supernatant respectively, and use a l...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a liquid chromatographic analysis method for detecting the plasma concentrations of oxcarbazepine and an oxcarbazepine metabolite in blood. The method comprises the steps thata liquid chromatographic analysis instrument and an ultraviolet detector are used for calibrating a standard solution, and fitting is conducted to obtain a standard curve equation representing the concentration of oxcarbazepine and a standard curve equation representing the concentration of the oxcarbazepine metabolite separately, wherein the standard curve equation representing the concentrationof oxcarbazepine is that y1 is equal to the sum of b and the product of a and x1, and the standard curve equation representing the concentration of the oxcarbazepine metabolite is that y2 is equal tothe sum of d and the product of c and x2; a blood sample to be tested is taken, pretreated and detected by using the same liquid chromatographic analysis instrument and ultraviolet detector to obtainy1 and y2 values of the blood to be tested, the y1 and y2 values of the blood sample to be tested are substituted into the two standard curve equations respectively, the relative plasma concentrationsx1 and x2 of oxcarbazepine and the oxcarbazepine metabolite in the blood sample to be tested are obtained through calculation separately, the concentration of an internal standard substance working solution is known, and the plasma concentrations of oxcarbazepine and the oxcarbazepine metabolite in the blood sample to be tested can be obtained through calculation.

Description

technical field [0001] The invention relates to the technical field of clinical blood drug concentration monitoring of psychotropic drugs, in particular to a method for detecting the content of antiepileptic drug oxcarbazepine and its metabolites in blood. Background technique [0002] Oxcarbazepine (OXC) is a new type of antiepileptic drug, which is a 10-keto derivative of carbamazepine with the molecular formula C 15 h 12 N 2 o 2 , the specific structure is as figure 1 shown. This medicine is indicated for the treatment of partial and generalized tonic-clonic seizures in adults and children over 5 years of age. OXC has the characteristics of good tolerance and less drug-drug interactions, and is gradually replacing traditional antiepileptic drugs alone or in combination. OXC is rapidly absorbed orally, and is almost rapidly degraded into the active metabolite (hereinafter referred to as the metabolite) 10,11-dihydro-10-hydroxycarbazepine (Monohydroxycarbazepine, MHD)...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N30/06G01N30/02G01N30/74
CPCG01N30/02G01N30/06G01N30/74G01N2030/045
Inventor 魏斌贾永娟倪君君
Owner BEIJING HARMONY HEALTH MEDICAL DIAGNOSTICS CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products